Trial Profile
A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.; Organon; Schering-Plough
- 23 Aug 2008 New trial record.